COMPANY PROFILE / #301
Iterative Health
Cambridge, MAVenture Capital-Backed
OVERVIEW
Developer of a clinical research site network designed to speed up gastroenterology studies. The company offers a global network embedded into community care that utilizes artificial intelligence tools to streamline clinical trials, expand patient access, and support operational efficiency for research sites and sponsors, focusing on gastrointestinal, hepatology, obesity, and cardiology research to improve enrollment speed and trial efficiency, empowering clinical research sites and sponsors to bring life-changing treatments to market faster.
已融资273.12
最新估值1,300.00
员工数250
成立年份2017
公司概况
- Companies
- Iterative Health
- Description
- Developer of a clinical research site network designed to speed up gastroenterology studies. The company offers a global network embedded into community care that utilizes artificial intelligence tools to streamline clinical trials, expand patient access, and support operational efficiency for research sites and sponsors, focusing on gastrointestinal, hepatology, obesity, and cardiology research to improve enrollment speed and trial efficiency, empowering clinical research sites and sponsors to bring life-changing treatments to market faster.
- Website
- iterative.health
- HQ Location
- Cambridge, MA
- Year Founded
- 2017
- Keywords
- cancer diagnostics, clinical decision support, computer aided diagnostics, diagnostic tools, gastroenterologists device, healthcare data analytics, healthtech platform
- Competitors
- Dova, Docbot, Odin Vision, Virgo, Wision A.I., Agile Health, PENTAX Medical, Advanced Cell Diagnostics, Magentiq Eye, ai4gi, Virgo Health, FujiFilm, Medtronic, Olympus (Medical Manufacturing Operation in Norwalk)
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 273.12
- First Financing Date
- 15-May-2018
- First Financing Size
- 0.01
- First Financing Valuation
- —
- Last Financing Date
- 05-Feb-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- 1,300.00
- Last Financing Status
- —
- Last Known Valuation
- 1,300.00
- Last Known Valuation Date
- 05-Feb-2026
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- —
- Valuation Estimate Growth Rate
- 50.09%
- Active Investors
- 515 Ventures, Alumni Ventures, Breyer Capital, Clearlake Capital Group, Constellation (VC), DNX Ventures, EDBI, Fortius Ventures, Frederic Kerrest, GV, HaloHealth, IKJ Capital, Insight Partners (New York), Intrepid Growth Partners, Johnson & Johnson JJDC, Koru Capital (New York), Lee Shapiro, Lilly USA, MedTech Innovator, Micron Technology, Micron Ventures, Nathaniel Turner, Obvious Ventures, Operator Partners, P5 Health Ventures, Planet First Partners, Plug and Play, Reform Ventures, RFQ Ventures, Seae Ventures, Spectra Investments, Tau Ventures, Texas Medical Center, Time BioVentures, Valor Capital Group, Wavemaker Partners, Wavemaker Three-Sixty Health, Zachary Weinberg
- # Active Investors
- —
- Acquirers
- —
团队与联系人
- Employees
- 250
- Employee Growth %
- —
- Employee History
- 2026: 250, 2025: 144, 2024: 129, 2023: 151, 2022: 160, 2021: 75, 2020: 25, 2019: 20, 2018: 12
- Primary Contact
- Jonathan Ng
- Primary Contact Title
- Founder, Chief Executive Officer & Board Member
- Primary Contact Phone
- +1 (703) 343-0143
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 11.93%
- Growth Rate % Change
- 18.01%
- Growth Rate Percentile
- 100
- Size Multiple
- 32.83x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- 3,836
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 100
- Success Probability Over Time – 1 Year
- 20%
- Success Probability Over Time – 3 Year
- 40%
- Success Probability Over Time – 5 Year
- 61%
记录来源：public.companies · 原始序号 #301 · 所有字段均按数据库原值展示。